Chinese scientists have genetically tweaked a fungus to make protein-rich “meat”, which they say can be a low-cost, ...

Complete response (CR) observed in 70% (35/50) of patients with low-grade upper tract urothelial cancer (UTUC) who completed ...

Teva Pharmaceutical Industries has announced the findings from the final analysis of the real-world pan-European PEARL Phase ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemias Findings underscore potential to address unmet needs in multiple ...

Nature boasts incredible survivors capable of enduring extreme conditions, from scorching heat and freezing cold to nuclear ...

Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12 weeks observed after a ...

Single-step CD45-engager technology shows robust immune evasion with functional persistence in pre-clinical models- Phase 1 study to evaluate ‘off-the-shelf’ natural killer cell cancer immunotherapy ...

Cullinan Therapeutics (CGEM) shared updated clinical data from its Phase 1 study of CLN-049, a novel, investigational FLT3xCD3 bispecific T cell ...

Many North Americans, no matter how accepting they are of biotechnology in crops, are more queasy when it comes to tinkering ...

Debate over psychedelic legalization tends to focus on two extreme views: the need to speed therapeutic access to meet urgent ...

The Science Research Program at New Rochelle High School gives students a jump start in careers in advanced sciences.